healthy individual
[용어속성] Patient
Regulatory KIR + RA + T cells accumulate with age and are highly activated during viral respiratory disease
Original Paper
[키워드] accumulate
accumulated
activated
Activation
addition
Affect
age
aging
Blood
CD45RA
CD8
CD8+ T cells
characterized
coronavirus
COVID‐19
disease
explain
expresse
expressed
expression
feature
healthy individual
identify
Immune suppression
immunological
increase
Infection
Infectious disease
Influenza
influenza A
Influenza virus
killer‐cell immunoglobulin‐like receptors
KIR
marker
Older
older population
phenotypical
proliferation
Regulation
Regulatory
regulatory T cells
respiratory symptoms
respiratory viral
respiratory viral infection
subset
susceptibility
T cell
T cells
T‐cell
T‐cell response
T‐cell responses
T‐cell activation
unique
viral respiratory
viral respiratory disease
[DOI] 10.1111/acel.13372 PMC 바로가기 [Article Type] Original Paper
[DOI] 10.1111/acel.13372 PMC 바로가기 [Article Type] Original Paper
Blood DNA methylation and COVID-19 outcomes
Research
[키워드] acute respiratory distress syndrome (ARDS)
Analysis
Autoimmune disorders
Blood
blood sample
circulating
collected
contribute
controls
COVID-19
COVID-19 patient
COVID-19 progression
COVID-19 severity
CpG
disease
DNA
DNA methylation
expression of gene
Gene Expression
genome-wide analysis
healthy
healthy individual
Hospitalized
Human
immune response
leukocyte
methylated
Methylation
Mortality
not differ
Ontology
outcome
outcome measure
outcomes
pandemic
Patient
patients
performed
platform
Predictive
promoter region
Prospective
Region
regulate
reported
Result
supplementary material
the SARS-CoV-2
These data
viral infection
[DOI] 10.1186/s13148-021-01102-9 PMC 바로가기 [Article Type] Research
[DOI] 10.1186/s13148-021-01102-9 PMC 바로가기 [Article Type] Research
Transcriptional Changes in CD16+ Monocytes May Contribute to the Pathogenesis of COVID-19
CD16+ 단핵구의 전사 변화가 COVID-19의 발병에 기여할 수 있음
Immunology
[키워드] analyzed
Antigen presentation
apoptotic
caused
CD16
CD16+
CD16+ monocyte
CD16+ monocytes
Cell
cell activation
cell movement
change
changes in
characterized
contribute
contributing to
COVID-19
COVID-19 case
COVID-19 cases
COVID-19 pandemic
death
dysregulated
dysregulated immune response
elevated
expressed
expression
function
functions
gene signatures
Genes
healthy individual
healthy individuals
host response
immune cells
infiltration
Inflammation
Inflammatory
Inflammatory response
Inflammatory responses
innate immune cell
Innate immune cells
interferon
interferon response
involved
MHC class
mild case
mild cases
mitochondrial
Monocytes
Non-classical monocytes
Pathogenesis
PBMC
people with COVID-19
phenotype
RNA sequencing data
SARS-CoV-2
Severe case
severe cases
severity
severity of COVID-19
Single Cell
Single-cell transcriptomics
the disease
These cells
tissue repair
tissues
transcriptional change
Transcriptional changes
transcriptomic
upregulated
upregulation
Viral
viral infections
[DOI] 10.3389/fimmu.2021.665773 PMC 바로가기 [Article Type] Immunology
[DOI] 10.3389/fimmu.2021.665773 PMC 바로가기 [Article Type] Immunology
Circulating Type I Interferon Levels and COVID-19 Severity: A Systematic Review and Meta-Analysis
순환하는 제1형 인터페론 수치와 COVID-19 심각도: 체계적인 검토 및 메타 분석
Meta-Analysis
[키워드] 95% CI
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
age
antiviral response
antiviral responses
article
association
Biomarker
can not
caused
clinical evolution
clinical manifestation
clinical manifestations
clinical status
Comparative
complex
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID-19
COVID-19 patients
Critical
critical COVID-19 patients
critical patients
cytokine
Cytokines
database
demonstrated
determine
disease severity
elevated
evaluated
Evidence
evidence of
healthy individual
healthy individuals
IFN-α
IFN-I
IFN-α
immunological alteration
infections
interferon
interferon response
interferons
Level
limit of detection
marker
means
Meta-analysis
Mild
mild cases
Mild disease
no significant difference
outcome
outcomes
Pathogenesis
Patient
patients
performed
peripheral
plasma
Plasma levels
plasma protein
random effect
Reporting
respiratory
Result
resulting
review
SARS-CoV-2
SARS-COV-2 infection
severe acute respiratory syndrome Coronavirus
severe cases
Severe patient
severity
severity of COVID-19
Sex
significant difference
SMD
standardized mean difference
the MEDLINE
Type
Type I IFN
type I interferon
type I interferons
was measured
was performed
Web of Science
with mild disease
[DOI] 10.3389/fimmu.2021.657363 PMC 바로가기 [Article Type] Meta-Analysis
[DOI] 10.3389/fimmu.2021.657363 PMC 바로가기 [Article Type] Meta-Analysis
Automated, multiparametric monitoring of respiratory biomarkers and vital signs in clinical and home settings for COVID-19 patients
COVID-19 환자를 위한 임상 및 가정 환경에서 호흡기 바이오마커 및 바이탈 사인에 대한 자동화된 다중 매개변수 모니터링
Clinical Trial
Published on
Journal: Proceedings of the National Academy of Sciences of [Category] SARS, 바이오마커, 임상, 진단,
Journal: Proceedings of the National Academy of Sciences of [Category] SARS, 바이오마커, 임상, 진단,
[키워드] (heart rate
ambient
approach
automated
Biomarker
Biomarkers
biometrics
can be used
can not
capture
Care
Continuous
continuous monitoring
Conventional
Convolutional neural networks
correlation
correlations
cough
coughing
Course
COVID-19
COVID-19 infection
COVID-19 infections
COVID-19 pandemic
COVID-19 patient
COVID-19 patients
Data analysis
demographic groups
Digital health
disease
disease spread
Diseases
effort
events
feature
Frequency
Health care
health care workers
Health status
healthy control
healthy controls
healthy individual
heart rate
high fidelity
high risk
hospital
Immunity
individual
Infection
Infectious diseases
infectiousness
intensity
limitations
methodology
monitoring system
overcome
parameter
Patient
physiological
populations
Probability
quantitative measurement
respiratory
respiratory activity
Respiratory disease
respiratory rate
response
sick
Significance
Soft
Spread
temperature
Therapeutics
translational
Trial
Variation
vital sign
vital signs
wearable electronics
[DOI] 10.1073/pnas.2026610118 PMC 바로가기 [Article Type] Clinical Trial
[DOI] 10.1073/pnas.2026610118 PMC 바로가기 [Article Type] Clinical Trial
Metabolic biomarker profiling for identification of susceptibility to severe pneumonia and COVID-19 in the general population
일반 인구에서 중증 폐렴 및 COVID-19에 대한 감수성을 식별하기 위한 대사 바이오마커 프로파일링
Research Article
[키워드] Alter
amino acids
association
best
Biomarker
Biomarkers
Blood
blood sample
Blood samples
blood sampling
cardiometabolic disease
cardiometabolic diseases
change
chronic inflammation
circulating
collected
complement
condition
Course
COVID-19
COVID-19 pandemic
determine
develop
diabete
diabetes
diagnosed
died
disease onset
Diseases
elevated
eLife
event
fatty acids
General population
health condition
healthy individual
help
high risk
higher risk
highest
hospitalised
Human
Hypothesis
identify
Immunity
impair
include
individual
Infection
infections
Infectious disease
Infectious diseases
inhibited
investigated
life-threatening
lipids
liver
liver diseases
low-grade inflammation
lowest
measure
metabolic
molecular
molecules
NMR
nuclear
nuclear magnetic resonance
Odds ratio
Older age
other infectious diseases
performed
Pneumonia
Predictive
Predictive value
Proteins
provided
risk
Risk factors
severe COVID-19
severe pneumonia
susceptibility
the disease
UK biobank
United Kingdom
[DOI] 10.7554/eLife.63033 PMC 바로가기 [Article Type] Research Article
[DOI] 10.7554/eLife.63033 PMC 바로가기 [Article Type] Research Article
Comparative analysis of antibodies to SARS-CoV-2 between asymptomatic and convalescent patients
Article
[키워드] Abstract
ACE2 binding
analyzed
Anti-RBD IgG
anti-S
antibody
antibody cross-reactivity
Antibody Response
Asymptomatic
asymptomatic individual
Asymptomatic individuals
Comparative analysis
convalescent patient
coronavirus
correlation
COVID-19
COVID-19 patient
cross-reactivity
develop
effective
Health
healthy individual
highest
IgG
IgG antibody
immune response
Immunological response
immunology
Increased
individual
Infection control in health technology
pandemic
positive
post vaccination
protective immunity
Protein
RBD
Responder
responses
responses against
robust
SARS-CoV-2
SARS-CoV-2 antibody response
SARS-COV-2 infection
SARS-CoV-2 patient
SARS-CoV-2 symptomatic patient
SARS-CoV-2 viral
screened
Southeastern United State
spike
tested
Treatment
Vaccines
Virology
were assessed
without symptom
without symptoms
[DOI] 10.1016/j.isci.2021.102489 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.isci.2021.102489 PMC 바로가기 [Article Type] Article
High SARS-CoV-2 IgG/IGM seroprevalence in asymptomatic Congolese in Brazzaville, the Republic of Congo
콩고 공화국 브라자빌의 무증상 콩고인에서 높은 SARS-CoV-2 IgG/IGM 혈청 유병률
Article
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
Adults
analyzed
anti-SARS-CoV-2 antibodies
anti-SARS-CoV-2 antibody
antibody
Asymptomatic
blood sample
Blood samples
Chain Reaction
collected
conducted
coronavirus
coronavirus disease
Coronavirus disease 2019
country
Course
COVID-19
COVID-19 infection
COVID-19 infection status
evaluate
expected
facilitate
First wave
force
healthy individual
healthy individuals
healthy volunteer
IgG
IgG and IgM
IgG or IgM antibodies
IgM
IgM antibodies
Immunoglobulin
Immunoglobulin G
immunoglobulin M
incidence
introduced
measure
men
negative RT-PCR
oropharyngeal swab
over
participant
polymerase chain
polymerase chain reaction
positive
predict
progression
proportion
Protective
Rapid tests
resource
respiratory
reverse transcription
reverse transcription polymerase chain reaction
risk
RT-PCR
RT-PCR assay
SARS-CoV-2
seroconvert
serological
Serological tests
Seroprevalence
severe acute respiratory syndrome Coronavirus
significantly higher
subject
subjects
Swab
tested
the antibody
The Republic of the Congo.
women
[DOI] 10.1016/j.ijid.2020.12.065 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.ijid.2020.12.065 PMC 바로가기 [Article Type] Article
Acquired decrease of the C3b/C4b receptor (CR1, CD35) and increased C4d deposits on erythrocytes from ICU COVID-19 patients
ICU COVID-19 환자의 C3b/C4b 수용체(CR1, CD35) 획득 감소 및 적혈구의 C4d 침착 증가
Article
[키워드] Acquired
Activation
Activation factor
assisted ventilation
C3
C4
C4d
capillary
CD35
cell debris
clearance
Clinical severity
coated
complement
Complement activation
Course
COVID-19
COVID-19 patient
COVID-19 patients
CR1
cumulative
damage
decrease
disease
endothelial
erythrocyte
erythrocytes
Erythrocytes.
France
handling
healthy individual
healthy individuals
highlight
ICU
immune complex
immune pathophysiology
individuals
Inflammation
innate immune response
marker
measurement
mechanism
observation
organ
Organ transplant
parameter
Participation
pathophysiology
Patient
patients
Protein
receptor
regulate
Regulatory
rejection
reported
SARS-CoV-2
SLE
student
t-test
therapy
transplant rejection
Ventilation
Virus spike
were assessed
[DOI] 10.1016/j.imbio.2021.152093 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.imbio.2021.152093 PMC 바로가기 [Article Type] Article